Metformin in Pregnancy
Its time has not yet come
- Florence M. Brown, MD1,
- Jennifer Wyckoff, MD1,
- Janet A. Rowan, FRACP2,
- Lois Jovanovic, MD3,
- David A. Sacks, MD4 and
- Gerald G. Briggs, BPHARM5
- 1Joslin Diabetes Center, Boston, Massachusetts
- 2National Women’s Hospital, Epsom, New Zealand
- 3Sansum Diabetes Research Institute, Santa Barbara, California
- 4Kaiser Foundation Hospital, Bellflower, California
- 5Women’s Hospital, Long Beach Memorial Medical Center, Long Beach, California
- Address correspondence to Jennifer Wyckoff, MD, Joslin Diabetes Center, One Joslin Place, Boston, MA 02115. E-mail: jennifer.wyckoff{at}joslin.harvard.edu
The American Diabetes Association (ADA) responds to letters concerning published articles in Diabetes Care. It does not respond to letters concerning presentations at the ADA Annual Scientific Sessions or reports of such presentations.
The ADA held an entire conference on the treatment of gestational diabetes in November 2005, in which the use of metformin
was discussed.
On 12 June 2005, the ADA’s newsletter from the 65th Annual Scientific Sessions, the Bayside Tribune (1), ran a piece entitled “Metformin Shown to be Safe and Effective in Pregnancy”. The article erroneously stated that speakers
at a symposium answered “with a resounding ‘Yes’” to the question of whether metformin is safe and effective for diabetes
in pregnancy. We are concerned with that message.
A symposium entitled “Metformin in Pregnancy–Is it Safe? Does it Work?” discussed metformin in pregnancy. Dr. Clifford Bailey reviewed cellular mechanisms of metformin …
